MedTrace Logo

Evaluation of DTRAX Graft in Patients With Cervical Degenerative Disc Disease

NCT01616719 · Status: WITHDRAWN · Phase: NA · Type: INTERVENTIONAL

Last updated 2020-03-04

No results posted yet for this study

Summary

DTRAX Graft is used to relieve nerve pressure in the neck in order to provide relief for Cervical Degenerative Disc Disease. This study is being conducted to determine the effectiveness of the graft, and to find out whether or not it provides better results or faster healing than traditional ways of performing surgery for Cervical Degenerative Disc Disease.

Conditions

  • Cervical Spondylosis
  • Cervical Radiculopathy
  • Cervical Degenerative Disc Disease

Interventions

DEVICE

DTRAX Graft

DTRAX Graft is an allograft implant inserted to support spinal fusion.

Sponsors & Collaborators

  • Providence Medical Technology, Inc.

    lead INDUSTRY

Principal Investigators

  • Bruce McCormack, M.D. · Neurospine Institute Medical Group

  • Brian Andrews, M.D. · Office of Dr. Brian Andrews, Neurosurgery

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
35 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-05-31
Primary Completion
2014-02-28
Completion
2015-02-28

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01616719 on ClinicalTrials.gov